Imidazo-pyridine derivatives as ligands for GABA receptors
US6723735B1 · kind B1 · utility
9Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2002 |
| Grant date | Apr 20, 2004 |
| Priority date | — |
| Expiry date | Mar 18, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to 3-phenylimidazol[4,5-b]pyridine derivatives, that are selective ligands for GABAA receptors. These compounds are useful in the treatment and prevention of disorders of the central nervous system, including anxiety and convulsions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.